
Fast-Acting DMT Shows Promise for Depression in Trial
A groundbreaking trial in London shows that DMT, the shortest-acting psychedelic drug, helped nearly half of depression patients feel better within just one week. The fast-acting treatment could transform care by letting patients go home hours after treatment instead of days.
